Watch RBOT. Know when insiders buy.
One email the day a filing lands. Free.
RBOT
Vicarious Surgical Inc.
0.00
−0.02 −85.00%
USD · close Nov 13
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$50.2MNET CASH $569K52W 0.00 – 3.30SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 · Dec 31derived | — | — | — | −$9.3M | −$10.5M | — | — | −$9.3M | — | — | Mar 9 |
| Q3 2025 · Sep 30 | — | — | — | −$11.5M | −$11.1M | — | — | −$10.5M | — | — | Nov 12 |
| Q2 2025 · Jun 30 | — | — | — | −$13.5M | −$13.2M | — | — | −$13.5M | $0 | −$13.5M | Aug 12 |
| Q1 2025 · Mar 31 | — | — | — | −$15.7M | −$15.4M | — | — | −$11.8M | $5K | −$11.8M | May 12 |
| Q4 2024 · Dec 31derived | — | — | — | −$15M | −$13.9M | — | — | −$11.8M | — | — | Mar 9 |
| Q3 2024 · Sep 30 | — | — | — | −$17.8M | −$17.1M | — | — | −$12.7M | — | — | Nov 12 |
| Q2 2024 · Jun 30 | — | — | — | −$17.7M | −$15.2M | — | -2.59 | −$11M | $6K | −$11M | Aug 12 |
| Q1 2024 · Mar 31 | — | — | — | −$16.1M | −$17M | — | -0.10 | −$14.5M | $10K | −$14.5M | May 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$15.5M | −$13.1M | — | -0.06 | −$11.4M | $1M | −$12.4M | Mar 17 |
| Q3 2023 · Sep 30 | — | — | — | −$21.4M | −$15.7M | — | -0.10 | −$17.3M | $118K | −$17.4M | Nov 12 |
| Q2 2023 · Jun 30 | — | — | — | −$21.5M | −$15.3M | — | -3.62 | −$15.1M | $208K | −$15.3M | Aug 13 |
| Q1 2023 · Mar 31 | — | — | — | −$22.3M | −$26.9M | — | -0.21 | −$18.6M | $306K | −$18.9M | Apr 29 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$50M | −$50.2M | — | — | −$45.1M | $132K | −$45.2M | — | — |
| FY2024 · to Dec 31 | — | — | −$66.6M | −$63.2M | — | — | −$50M | $180K | −$50.1M | — | — |
| FY2023 · to Dec 31 | — | — | −$80.7M | −$71.1M | — | -0.49 | −$62.3M | $1.7M | −$64M | — | — |
| FY2022 · to Dec 31 | — | — | −$80.1M | $5.2M | — | 0.04 | −$61.2M | $5.4M | −$66.6M | — | — |
| FY2021 · to Dec 31 | — | — | −$38.2M | −$35.2M | — | -0.36 | −$33.3M | $1.3M | −$34.6M | — | — |
| FY2020 · to Dec 31 | — | — | −$13M | −$12.9M | — | -0.16 | −$12M | $120K | −$12.2M | — | — |
Every number comes from Vicarious Surgical Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.